diabetes glp-1 agonist New Guidelines for Type 2 in 2025 Current Insights, Advantages and Challenges
Description
The exocrine pancreas has GLP-1 receptors, mainly on the acinar cells
d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes
At the present moment, there are currently no FDA approved medications for NASH
Clinical studies have shown that these medications reduce glucose levels in people with diabetes without the problems of weight gain or risk of low glucose associated with some other diabetes treatments
